NEW YORK, Aug. 31, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Forterra, Inc. (NASDAQ:FRTA) who purchased shares between October 18, 2016 and August 14, 2017 and/or pursuant and/or traceable to the Company’s October 21, 2016 Initial Public Offering. The action, which was filed in the United States District Court for the Eastern District of New York, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that the Registration Statement used to conduct the IPO contained inaccurate statements and omitted material information including that: (1) at the time of the IPO, organic sales in Forterra’s Drainage and Water segments had significantly declined; (2) Forterra was experiencing increased pricing pressure due to competition and continued softness in its concrete and steel pipe business; (3) Forterra had been losing business in its important pipe and precast business due in large part to operational problems at its production plants; and (4) Forterra had undisclosed material weaknesses in its internal controls that prevented it from accurately reporting and forecasting its financial results.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sbm/forterra-inc?wire=3.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 



